BioPharma Dive3d
Leqembi’s EU review drags on; Sanofi gets a new development head
The European Commission has referred Eisai and Biogen’s application to an appeals committee. Elsewhere, Opthea warned of ...
Fierce Biotech4d
Sanofi taps Nurix for pipeline nourishment once again, picking up autoimmune degrader for $15M
Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, paying $15 million and committing up to $465 ...